223 related articles for article (PubMed ID: 27227539)
1. The Contribution of GWAS Loci in Familial Dyslipidemias.
Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
[TBL] [Abstract][Full Text] [Related]
2. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.
Juo SH; Bredie SJ; Kiemeney LA; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1998 Aug; 63(2):586-94. PubMed ID: 9683593
[TBL] [Abstract][Full Text] [Related]
3. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
[TBL] [Abstract][Full Text] [Related]
5. [Familial combined hyperlipidemia - the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease].
Vaverková H; Karásek D
Vnitr Lek; 2018; 64(1):25-29. PubMed ID: 29498872
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
7. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
8. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
9. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
[TBL] [Abstract][Full Text] [Related]
10. Familial combined hyperlipidemia is a polygenic trait.
Gill PK; Hegele RA
Curr Opin Lipidol; 2022 Apr; 33(2):126-132. PubMed ID: 34690300
[TBL] [Abstract][Full Text] [Related]
11. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
12. Familial hypoalphalipoproteinemia in premature coronary artery disease.
Genest J; Bard JM; Fruchart JC; Ordovas JM; Schaefer EJ
Arterioscler Thromb; 1993 Dec; 13(12):1728-37. PubMed ID: 8241092
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
[TBL] [Abstract][Full Text] [Related]
14. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
15. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.
Allayee H; Aouizerat BE; Cantor RM; Dallinga-Thie GM; Krauss RM; Lanning CD; Rotter JI; Lusis AJ; de Bruin TW
Am J Hum Genet; 1998 Aug; 63(2):577-85. PubMed ID: 9683614
[TBL] [Abstract][Full Text] [Related]
16. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants influencing lipid levels and risk of dyslipidemia in Chinese population.
Luo H; Zhang X; Shuai P; Miao Y; Ye Z; Lin Y
J Genet; 2017 Dec; 96(6):985-992. PubMed ID: 29321358
[TBL] [Abstract][Full Text] [Related]
18. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
[TBL] [Abstract][Full Text] [Related]
19. The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.
van der Vleuten GM; Kluijtmans LA; Hijmans A; Blom HJ; Stalenhoef AF; de Graaf J
Int J Obes (Lond); 2006 Jun; 30(6):892-8. PubMed ID: 16432543
[TBL] [Abstract][Full Text] [Related]
20. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
Bredie SJ; Kiemeney LA; de Haan AF; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1996 Apr; 58(4):812-22. PubMed ID: 8644746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
